231O Locoregional hypo vs normofractionated RT in early breast cancer: 5 years results of the HypoG-01 phase III UNICANCER trial

Silvina Torres Rivera, Robabeh Ghodssi-Ghassemabadi, Triza Brion, Y. Kirova, S. Racadot, M. Benchalal, Jean-Baptiste Clavier, C. Brunaud, Marie-Eve Fouche-Chand, Delphine Argo Leignel, K. Peignaux-Casasnovas, Ahmed Benyoucef, D. Pasquier, P. Guilbert, J. Blanchecotte, Gladys Phothirath, Assia Lamrani-Ghaouti, Marie Bergeaud, Guillaume Auzac, Stefan Michiels